Víctor Grijalva

4.5k total citations
59 papers, 3.7k citations indexed

About

Víctor Grijalva is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Víctor Grijalva has authored 59 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Clinical Biochemistry and 18 papers in Surgery. Recurrent topics in Víctor Grijalva's work include Paraoxonase enzyme and polymorphisms (19 papers), Cholesterol and Lipid Metabolism (11 papers) and Cancer, Lipids, and Metabolism (7 papers). Víctor Grijalva is often cited by papers focused on Paraoxonase enzyme and polymorphisms (19 papers), Cholesterol and Lipid Metabolism (11 papers) and Cancer, Lipids, and Metabolism (7 papers). Víctor Grijalva collaborates with scholars based in United States, Canada and China. Víctor Grijalva's co-authors include Srinivasa T. Reddy, Alan M. Fogelman, Mohamad Navab, Susan Hama, Carey J. Ng, Greg Hough, David J. Wadleigh, Alan C. Wagner, Diana M. Shih and G.M. Anantharamaiah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Víctor Grijalva

58 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Víctor Grijalva United States 33 1.1k 1.1k 1.0k 718 619 59 3.7k
Charles L. Bisgaier United States 29 1.3k 1.2× 1.4k 1.3× 1.4k 1.4× 932 1.3× 473 0.8× 57 4.4k
Ganesamoorthy Subbanagounder United States 27 827 0.7× 1.3k 1.2× 1.8k 1.7× 714 1.0× 324 0.5× 29 5.2k
Ewa Ninio France 37 417 0.4× 1.2k 1.1× 1.4k 1.3× 570 0.8× 507 0.8× 103 4.1k
M. Navab United States 13 1.0k 0.9× 663 0.6× 760 0.7× 487 0.7× 150 0.2× 15 2.9k
Amir Ravandi Canada 36 383 0.3× 999 0.9× 1.2k 1.1× 442 0.6× 318 0.5× 145 3.8k
Brian J. Van Lenten United States 42 1.3k 1.1× 2.7k 2.4× 1.6k 1.6× 2.0k 2.8× 921 1.5× 57 6.9k
Monica Gomaraschi Italy 28 273 0.2× 933 0.9× 581 0.6× 798 1.1× 359 0.6× 64 2.3k
Jerzy–Roch Nofer Germany 36 343 0.3× 2.0k 1.8× 2.0k 1.9× 1.3k 1.9× 628 1.0× 104 5.0k
Laura Calabresi Italy 49 589 0.5× 3.8k 3.5× 2.2k 2.1× 3.0k 4.2× 1.2k 2.0× 230 7.7k
Gopal K. Marathe United States 32 252 0.2× 466 0.4× 1.5k 1.4× 213 0.3× 234 0.4× 69 3.3k

Countries citing papers authored by Víctor Grijalva

Since Specialization
Citations

This map shows the geographic impact of Víctor Grijalva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Grijalva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Grijalva more than expected).

Fields of papers citing papers by Víctor Grijalva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Grijalva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Grijalva. The network helps show where Víctor Grijalva may publish in the future.

Co-authorship network of co-authors of Víctor Grijalva

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Grijalva. A scholar is included among the top collaborators of Víctor Grijalva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Grijalva. Víctor Grijalva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charles‐Schoeman, Christina, Jennifer Wang, Ani Shahbazian, et al.. (2020). Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice. Scientific Reports. 10(1). 16848–16848. 14 indexed citations
2.
Devarajan, Asokan, Feng Su, Víctor Grijalva, et al.. (2018). Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death and Disease. 9(3). 392–392. 27 indexed citations
3.
Singh, Rajan, Shehla Pervin, Se‐Jin Lee, et al.. (2018). Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases. Diabetes Metabolic Syndrome and Obesity. Volume 11. 65–84. 18 indexed citations
4.
Chattopadhyay, A., Xinying Yang, Dawoud Sulaiman, et al.. (2018). Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Scientific Reports. 8(1). 9032–9032. 33 indexed citations
5.
Singh, Rajan, Melissa Braga, Srinivasa T. Reddy, et al.. (2017). Follistatin Targets Distinct Pathways To Promote Brown Adipocyte Characteristics in Brown and White Adipose Tissues. Endocrinology. 158(5). 1217–1230. 45 indexed citations
6.
Chattopadhyay, A., Mohamad Navab, Greg Hough, et al.. (2016). Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. Journal of Lipid Research. 57(5). 832–847. 21 indexed citations
7.
Meriwether, David, Dawoud Sulaiman, Alan C. Wagner, et al.. (2016). Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux. Journal of Lipid Research. 57(7). 1175–1193. 20 indexed citations
8.
Braga, Melissa, Srinivasa T. Reddy, Laurent Vergnes, et al.. (2014). Follistatin promotes adipocyte differentiation, browning, and energy metabolism. Journal of Lipid Research. 55(3). 375–384. 92 indexed citations
9.
Devarajan, Asokan, Noam Bourquard, Víctor Grijalva, et al.. (2013). Role of PON2 in innate immune response in an acute infection model. Molecular Genetics and Metabolism. 110(3). 362–370. 32 indexed citations
10.
Chattopadhyay, A., Mohamad Navab, Greg Hough, et al.. (2013). A novel approach to oral apoA-I mimetic therapy. Journal of Lipid Research. 54(4). 995–1010. 73 indexed citations
11.
Devarajan, Asokan, Ines Witte, Petra Wilgenbus, et al.. (2012). PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death and Differentiation. 19(9). 1549–1560. 71 indexed citations
12.
Hong, Cynthia, Xin Rong, Xuping Wang, et al.. (2012). LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. Journal of Lipid Research. 53(6). 1126–1133. 37 indexed citations
13.
Ganapathy, Ekambaram, Feng Su, David Meriwether, et al.. (2011). D‐4F, an apoA‐I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. International Journal of Cancer. 130(5). 1071–1081. 57 indexed citations
14.
Gao, Feng, Feng Su, Neha Shah, et al.. (2011). L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integrative Biology. 3(4). 479–479. 62 indexed citations
15.
Su, Feng, Víctor Grijalva, J. H. Pope, et al.. (2011). Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium. PLoS ONE. 6(4). e19099–e19099. 50 indexed citations
16.
Devarajan, Asokan, Noam Bourquard, Susan Hama, et al.. (2010). Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of Atherosclerosis. Antioxidants and Redox Signaling. 14(3). 341–351. 150 indexed citations
17.
Watanabe, Junji, Víctor Grijalva, Susan Hama, et al.. (2009). Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein. Journal of Biological Chemistry. 284(27). 18292–18301. 93 indexed citations
18.
Watanabe, Junji, Katherine Chou, James C. Liao, et al.. (2007). Differential Association of Hemoglobin with Proinflammatory High Density Lipoproteins in Atherogenic/Hyperlipidemic Mice. Journal of Biological Chemistry. 282(32). 23698–23707. 69 indexed citations
19.
Navab, Mohamad, Srinivasa T. Reddy, Brian J. Van Lenten, et al.. (2005). The double jeopardy of HDL. Annals of Medicine. 37(3). 173–178. 116 indexed citations
20.
Reddy, Srinivasa T., Víctor Grijalva, Carey J. Ng, et al.. (2002). Identification of genes induced by oxidized phospholipids in human aortic endothelial cells. Vascular Pharmacology. 38(4). 211–218. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles L. Bisgaier Breakdown of academic impact, for papers by Ganesamoorthy Subbanagounder Breakdown of academic impact, for papers by Ewa Ninio Breakdown of academic impact, for papers by M. Navab Breakdown of academic impact, for papers by Amir Ravandi Breakdown of academic impact, for papers by Brian J. Van Lenten Breakdown of academic impact, for papers by Monica Gomaraschi Breakdown of academic impact, for papers by Jerzy–Roch Nofer Breakdown of academic impact, for papers by Laura Calabresi Breakdown of academic impact, for papers by Gopal K. Marathe
Rankless by CCL
2026